Korea United Pharm. Inc.
Clinical trials sponsored by Korea United Pharm. Inc., explained in plain language.
A South Korean pharmaceutical company producing generic and specialty drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New cholesterol drugs enter human testing for first time
Disease control CompletedThis early-stage trial tests two experimental drugs, UI111 and UIC202006, in healthy adult volunteers. The goal is to check the drugs' safety and how the body processes them after a single dose taken with food. The study uses a crossover design, meaning each participant receives …
Phase: PHASE1 • Sponsor: Korea United Pharm. Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug combo aims to ease leg pain from clogged arteries
Disease control CompletedThis Phase 3 trial tested whether adding cilostazol to rosuvastatin helps people with peripheral artery disease (PAD) more than rosuvastatin alone. PAD narrows leg arteries, causing pain and trouble walking. The study enrolled 260 adults who took either the combo or a placebo for…
Phase: PHASE3 • Sponsor: Korea United Pharm. Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can two experimental drugs be taken together safely? a trial seeks answers
Knowledge-focused CompletedThis trial investigates whether two experimental drugs, UIC202304 and UIC202305, can be taken together without harmful interactions. Healthy volunteers aged 19 to 55 will take one or both drugs in sequence, and researchers will measure how the drugs move through the body and any …
Phase: PHASE1 • Sponsor: Korea United Pharm. Inc. • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC